Literature DB >> 2682733

Clozapine in China: a review and preview of US/PRC collaboration.

W Z Potter1, G N Ko, L D Zhang, W W Yan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2682733     DOI： 10.1007/bf00442568

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN： 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  9 in total

1.  Antagonism by neuroleptics of neurotransmitter receptors of normal human brain in vitro.

Authors:  E Richelson; A Nelson
Journal:  Eur J Pharmacol       Date:  1984-08-17       Impact factor: 4.432

2.  Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons.

Authors:  F J White; R Y Wang
Journal:  Science       Date:  1983-09-09       Impact factor: 47.728

3.  Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine.

Authors:  J Kane; G Honigfeld; J Singer; H Meltzer
Journal:  Arch Gen Psychiatry       Date:  1988-09

Review 4.  Changing epidemiology of tardive dyskinesia: an overview.

Authors:  D V Jeste; R J Wyatt
Journal:  Am J Psychiatry       Date:  1981-03       Impact factor: 18.112

5.  Plasma homovanillic acid concentration and the severity of schizophrenic illness.

Authors:  K L Davis; M Davidson; R C Mohs; K S Kendler; B M Davis; C A Johns; Y DeNigris; T B Horvath
Journal:  Science       Date:  1985-03-29       Impact factor: 47.728

6.  Plasma catecholamine metabolites and early response to haloperidol.

Authors:  M B Bowers; M E Swigar; P I Jatlow; N Goicoechea
Journal:  J Clin Psychiatry       Date:  1984-06       Impact factor: 4.384

7.  Rapid and simple determination of homovanillic acid in plasma using high performance liquid chromatography with electrochemical detection.

Authors:  W H Chang; M Scheinin; R S Burns; M Linnoila
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1983-10

8.  Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons.

Authors:  L A Chiodo; B S Bunney
Journal:  J Neurosci       Date:  1983-08       Impact factor: 6.167

9.  Longitudinal measurement of plasma homovanillic acid levels in schizophrenic patients. Correlation with psychosis and response to neuroleptic treatment.

Authors:  D Pickar; R Labarca; A R Doran; O M Wolkowitz; A Roy; A Breier; M Linnoila; S M Paul
Journal:  Arch Gen Psychiatry       Date:  1986-07
  9 in total
  12 in total

Review 1.  Predictors and markers of clozapine response.

Authors:  Carmen Chung; Gary Remington
Journal:  Psychopharmacology (Berl)       Date:  2005-02-17       Impact factor: 4.530

Review 2.  Augmentation strategies in clozapine-resistant schizophrenia.

Authors:  Gary Remington; Amitabha Saha; Siow-Ann Chong; Chekkera Shammi
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

3.  Pimozide augmentation of clozapine inpatients with schizophrenia and schizoaffective disorder unresponsive to clozapine monotherapy.

Authors:  Joseph I Friedman; Jean-Pierre Lindenmayer; Frances Alcantara; Stephanie Bowler; Mohan Parak; Leonard White; Adel Iskander; Michael Parrella; David N Adler; Nicholas D Tsopelas; Wei-Yann Tsai; Vladan Novakovic; Vladan Novakovick; Philip D Harvey; Kenneth L Davis; Saurabh Kaushik
Journal:  Neuropsychopharmacology       Date:  2011-02-23       Impact factor: 7.853

Review 4.  Antipsychotic combinations for schizophrenia.

Authors:  Javier Ortiz-Orendain; Santiago Castiello-de Obeso; Luis Enrique Colunga-Lozano; Yue Hu; Nicola Maayan; Clive E Adams
Journal:  Cochrane Database Syst Rev       Date:  2017-06-28

5.  Prevalence and severity of antipsychotic related constipation in patients with schizophrenia: a retrospective descriptive study.

Authors:  Marc De Hert; Liesbeth Dockx; Chiara Bernagie; Bie Peuskens; Kim Sweers; Stefan Leucht; Jan Tack; Stefan Van de Straete; Martien Wampers; Joseph Peuskens
Journal:  BMC Gastroenterol       Date:  2011-03-08       Impact factor: 3.067

6.  Mechanism of clozapine-induced agranulocytosis : current status of research and implications for drug development.

Authors:  M Pirmohamed; K Park
Journal:  CNS Drugs       Date:  1997-02       Impact factor: 5.749

Review 7.  Pharmacokinetics and pharmacodynamics of clozapine.

Authors:  M W Jann; S R Grimsley; E C Gray; W H Chang
Journal:  Clin Pharmacokinet       Date:  1993-02       Impact factor: 6.447

8.  Antipsychotic combinations vs monotherapy in schizophrenia: a meta-analysis of randomized controlled trials.

Authors:  Christoph U Correll; Christine Rummel-Kluge; Caroline Corves; John M Kane; Stefan Leucht
Journal:  Schizophr Bull       Date:  2008-04-15       Impact factor: 9.306

9.  Long-term antipsychotic polypharmacy in the VA health system: patient characteristics and treatment patterns.

Authors:  Julie A Kreyenbuhl; Marcia Valenstein; John F McCarthy; Dara Ganoczy; Frederic C Blow
Journal:  Psychiatr Serv       Date:  2007-04       Impact factor: 3.084

Review 10.  Clozapine versus typical neuroleptic medication for schizophrenia.

Authors:  Adib Essali; Nahla Al-Haj Haasan; Chunbo Li; John Rathbone
Journal:  Cochrane Database Syst Rev       Date:  2009-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.